Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies

OBJECTIVE—Observational studies assessing the association of combination therapy of metformin and sulfonylurea on all-cause and/or cardiovascular mortality in type 2 diabetes have shown conflicting results. We therefore evaluated the effects of combination therapy of sulfonylureas and metformin on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Ajay D., Kuhadiya, Nitesh, Reynolds, Kristi, Fonseca, Vivian A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Reviews/Commentaries/ADA Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494623/
https://www.ncbi.nlm.nih.gov/pubmed/18458139
http://dx.doi.org/10.2337/dc08-0167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494623/
https://www.ncbi.nlm.nih.gov/pubmed/18458139
http://dx.doi.org/10.2337/dc08-0167

Ejemplares similares